{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:23:19Z","timestamp":1792819399337,"version":"4.5.0"},"reference-count":154,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s12185-025-03918-0","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T19:09:47Z","timestamp":1738350587000},"page":"633-652","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024: part 4\u2014trauma, burn, obstetrics, acute pancreatitis\/liver failure, and others"],"prefix":"10.1007","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8341-7626","authenticated-orcid":false,"given":"Mineji","family":"Hayakawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Seki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Ikezoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohji","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Kushimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Itagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyasu","family":"Ishikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Mayumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihisa","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Kawazoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayami","family":"Shigeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudai","family":"Takatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Tampo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noritaka","family":"Yada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Kiyokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoru","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Uchiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidesaku","family":"Asakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Madoiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimasa","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Iba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Gando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Committee of the Clinical Practice Guidelines for Disseminated Intravascular Coagulation 2024, the Japanese Society on Thrombosis, Hemostasis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"issue":"1","key":"3918_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.thromres.2009.08.017","volume":"125","author":"H Wada","year":"2010","unstructured":"Wada H, Asakura H, Okamoto K, Iba T, Uchiyama T, Kawasugi K, et al. Expert consensus for the treatment of disseminated intravascular coagulation in Japan. Thromb Res. 2010;125(1):6\u201311. https:\/\/doi.org\/10.1016\/j.thromres.2009.08.017.","journal-title":"Thromb Res"},{"issue":"1","key":"3918_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1365-2141.2009.07600.x","volume":"145","author":"M Levi","year":"2009","unstructured":"Levi M, Toh CH, Thachil J, Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. Br J Haematol. 2009;145(1):24\u201333. https:\/\/doi.org\/10.1111\/j.1365-2141.2009.07600.x.","journal-title":"Br J Haematol"},{"issue":"5","key":"3918_CR3","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1016\/j.thromres.2011.08.028","volume":"129","author":"M Di Nisio","year":"2012","unstructured":"Di Nisio M, Baudo F, Cosmi B, D\u2019Angelo A, De Gasperi A, Malato A, et al. Diagnosis and treatment of disseminated intravascular coagulation: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thromb Res. 2012;129(5):e177\u201384. https:\/\/doi.org\/10.1016\/j.thromres.2011.08.028.","journal-title":"Thromb Res"},{"issue":"1","key":"3918_CR4","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s13054-017-1811-1","volume":"21","author":"M Hayakawa","year":"2017","unstructured":"Hayakawa M, Maekawa K, Kushimoto S, Kato H, Sasaki J, Ogura H, et al. Hyperfibrinolysis in severe isolated traumatic brain injury may occur without tissue hypoperfusion: a retrospective observational multicentre study. Crit Care. 2017;21(1):222. https:\/\/doi.org\/10.1186\/s13054-017-1811-1.","journal-title":"Crit Care"},{"issue":"3","key":"3918_CR5","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1097\/SHK.0000000000000542","volume":"45","author":"M Hayakawa","year":"2016","unstructured":"Hayakawa M, Maekawa K, Kushimoto S, Kato H, Sasaki J, Ogura H, et al. High D-dimer levels predict a poor outcome in patients with severe trauma, even with high fibrinogen levels on arrival: a multicenter retrospective study. Shock. 2016;45(3):308\u201314. https:\/\/doi.org\/10.1097\/SHK.0000000000000542.","journal-title":"Shock"},{"issue":"1","key":"3918_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1055\/s-0034-1398379","volume":"41","author":"M Hayakawa","year":"2015","unstructured":"Hayakawa M, Gando S, Ono Y, Wada T, Yanagida Y, Sawamura A. Fibrinogen level deteriorates before other routine coagulation parameters and massive transfusion in the early phase of severe trauma: a retrospective observational study. Semin Thromb Hemost. 2015;41(1):35\u201342. https:\/\/doi.org\/10.1055\/s-0034-1398379.","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"3918_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.injury.2010.11.003","volume":"43","author":"B Floccard","year":"2012","unstructured":"Floccard B, Rugeri L, Faure A, Saint Denis M, Boyle EM, Peguet O, et al. Early coagulopathy in trauma patients: an on-scene and hospital admission study. Injury. 2012;43(1):26\u201332. https:\/\/doi.org\/10.1016\/j.injury.2010.11.003.","journal-title":"Injury"},{"issue":"3","key":"3918_CR8","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/jth.14690","volume":"18","author":"HB Moore","year":"2020","unstructured":"Moore HB, Gando S, Iba T, Kim PY, Yeh CH, Brohi K, et al. Defining trauma-induced coagulopathy with respect to future implications for patient management: communication from the SSC of the ISTH. JTH. 2020;18(3):740\u20137. https:\/\/doi.org\/10.1111\/jth.14690.","journal-title":"JTH"},{"key":"3918_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14450","author":"LZ Kornblith","year":"2019","unstructured":"Kornblith LZ, Moore HB, Cohen MJ. Trauma-induced coagulopathy: the past, present, and future. JTH. 2019. https:\/\/doi.org\/10.1111\/jth.14450.","journal-title":"JTH"},{"issue":"9","key":"3918_CR10","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1111\/jth.14520","volume":"17","author":"S Gando","year":"2019","unstructured":"Gando S, Otomo Y. Trauma-induced coagulopathy: the past, present, and future: a comment. JTH. 2019;17(9):1567\u20139. https:\/\/doi.org\/10.1111\/jth.14520.","journal-title":"JTH"},{"issue":"9","key":"3918_CR11","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1111\/jth.14571","volume":"17","author":"T Wada","year":"2019","unstructured":"Wada T, Yamakawa K. Trauma-induced coagulopathy: the past, present, and future: a comment. JTH. 2019;17(9):1571\u20134. https:\/\/doi.org\/10.1111\/jth.14571.","journal-title":"JTH"},{"key":"3918_CR12","doi-asserted-by":"publisher","unstructured":"Rossaint R, Afshari A, Bouillon B, Cerny V, Cimpoesu D, Curry N et al. The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition. Crit Care. 2023; 27(1): 80. https:\/\/doi.org\/10.1186\/s13054-023-04327-7.","DOI":"10.1186\/s13054-023-04327-7"},{"issue":"5","key":"3918_CR13","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1001\/jama.2015.12","volume":"313","author":"JB Holcomb","year":"2015","unstructured":"Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015;313(5):471\u201382. https:\/\/doi.org\/10.1001\/jama.2015.12.","journal-title":"JAMA"},{"key":"3918_CR14","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jocn.2022.05.016","volume":"101","author":"M Sabouri","year":"2022","unstructured":"Sabouri M, Vahidian M, Sourani A, Mahdavi SB, Tehrani DS, Shafiei E. Efficacy and safety of fibrinogen administration in acute post-traumatic hypofibrinogenemia in isolated severe traumatic brain injury: a randomized clinical trial. J Clin Neurosci. 2022;101:204\u201311. https:\/\/doi.org\/10.1016\/j.jocn.2022.05.016.","journal-title":"J Clin Neurosci"},{"key":"3918_CR15","doi-asserted-by":"publisher","first-page":"e3168","DOI":"10.6061\/clinics\/2021\/e3168","volume":"76","author":"LS Lucena","year":"2021","unstructured":"Lucena LS, Rodrigues RDR, Carmona MJC, Noronha FJD, Oliveira HP, Lima NM, et al. Early administration of fibrinogen concentrate in patients with polytrauma with thromboelastometry suggestive of hypofibrinogenemia: a randomized feasibility trial. Clin. 2021;76:e3168. https:\/\/doi.org\/10.6061\/clinics\/2021\/e3168.","journal-title":"Clin"},{"issue":"11","key":"3918_CR16","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/j.ajem.2018.02.018","volume":"36","author":"E Akbari","year":"2018","unstructured":"Akbari E, Safari S, Hatamabadi H. The effect of fibrinogen concentrate and fresh-frozen plasma on the outcome of patients with acute traumatic coagulopathy: a quasi-experimental study. Am J Emerg Med. 2018;36(11):1947\u201350. https:\/\/doi.org\/10.1016\/j.ajem.2018.02.018.","journal-title":"Am J Emerg Med"},{"key":"3918_CR17","doi-asserted-by":"publisher","unstructured":"Jehan F, Aziz H, O\u02bcKeeffe T, Khan M, Zakaria ER, Hamidi M et al. The role of four-factor prothrombin complex concentrate in coagulopathy of trauma: a propensity matched analysis. J Trauma Acute Care Surg. 2018; 85(1):18\u201324. https:\/\/doi.org\/10.1097\/TA.0000000000001938.","DOI":"10.1097\/TA.0000000000001938"},{"issue":"12","key":"3918_CR18","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/BOT.0000000000000665","volume":"30","author":"B Joseph","year":"2016","unstructured":"Joseph B, Khalil M, Harrison C, Swartz T, Kulvatunyou N, Haider AA, et al. Assessing the efficacy of prothrombin complex concentrate in multiply injured patients with high-energy pelvic and extremity fractures. J Orthop Trauma. 2016;30(12):653\u20138. https:\/\/doi.org\/10.1097\/BOT.0000000000000665.","journal-title":"J Orthop Trauma"},{"issue":"6","key":"3918_CR19","doi-asserted-by":"publisher","first-page":"e258","DOI":"10.1016\/S2352-3026(17)30077-7","volume":"4","author":"P Innerhofer","year":"2017","unstructured":"Innerhofer P, Fries D, Mittermayr M, Innerhofer N, von Langen D, Hell T, et al. Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh-frozen plasma (RETIC): a single-centre, parallel-group, open-label, randomised trial. Lancet Haematol. 2017;4(6):e258\u201371. https:\/\/doi.org\/10.1016\/S2352-3026(17)30077-7.","journal-title":"Lancet Haematol"},{"issue":"1","key":"3918_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/mbc.0000000000000021","volume":"25","author":"D Yao","year":"2014","unstructured":"Yao D, Li Y, Wang J, Yu W, Li N, Li J. Effects of recombinant activated factor VIIa on abdominal trauma patients. Blood Coagul Fibrinolysis. 2014;25(1):33\u20138. https:\/\/doi.org\/10.1097\/mbc.0000000000000021.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"2","key":"3918_CR21","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/TA.0b013e3181bbfb6b","volume":"68","author":"CV Brown","year":"2010","unstructured":"Brown CV, Foulkrod KH, Lopez D, Stokes J, Villareal J, Foarde K, et al. Recombinant factor VIIa for the correction of coagulopathy before emergent craniotomy in blunt trauma patients. J Trauma. 2010;68(2):348\u201352. https:\/\/doi.org\/10.1097\/TA.0b013e3181bbfb6b.","journal-title":"J Trauma"},{"key":"3918_CR22","doi-asserted-by":"publisher","unstructured":"Stein DM, Dutton RP, Kramer ME, Scalea TM. Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma. J Trauma. 2009; 66(1): 63\u201372. https:\/\/doi.org\/10.1097\/TA.0b013e318191bc8a (discussion 3\u20135).","DOI":"10.1097\/TA.0b013e318191bc8a"},{"issue":"1","key":"3918_CR23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jcrc.2014.07.009","volume":"30","author":"Q Yuan","year":"2015","unstructured":"Yuan Q, Wu X, Du ZY, Sun YR, Yu J, Li ZQ, et al. Low-dose recombinant factor VIIa for reversing coagulopathy in patients with isolated traumatic brain injury. J Crit Care. 2015;30(1):116\u201320. https:\/\/doi.org\/10.1016\/j.jcrc.2014.07.009.","journal-title":"J Crit Care"},{"key":"3918_CR24","doi-asserted-by":"publisher","unstructured":"Collaborators Crash-trial, Shakur H, Roberts I, Bautista R, Caballero J, Coats T et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010; 376(9734): 23\u201332. https:\/\/doi.org\/10.1016\/S0140-6736(10)60835-5.","DOI":"10.1016\/S0140-6736(10)60835-5"},{"issue":"10210","key":"3918_CR25","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/S0140-6736(19)32233-0","volume":"394","author":"C Crash-trial","year":"2019","unstructured":"Crash-trial C. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet. 2019;394(10210):1713\u201323. https:\/\/doi.org\/10.1016\/S0140-6736(19)32233-0.","journal-title":"Lancet"},{"issue":"4","key":"3918_CR26","doi-asserted-by":"publisher","first-page":"339","DOI":"10.5603\/AIT.a2015.0011","volume":"47","author":"W Ng","year":"2015","unstructured":"Ng W, Jerath A, W\u0105sowicz M. Tranexamic acid: a clinical review. Anaesthesiol Intensive Ther. 2015;47(4):339\u201350. https:\/\/doi.org\/10.5603\/AIT.a2015.0011.","journal-title":"Anaesthesiol Intensive Ther"},{"key":"3918_CR27","doi-asserted-by":"publisher","unstructured":"Ker K, Roberts I, Shakur H, Coats TJ. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev. 2015; 2015(5): Cd004896. https:\/\/doi.org\/10.1002\/14651858.CD004896.pub4.","DOI":"10.1002\/14651858.CD004896.pub4"},{"issue":"4","key":"3918_CR28","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1007\/s00134-007-0976-5","volume":"34","author":"A Lavrentieva","year":"2008","unstructured":"Lavrentieva A, Kontakiotis T, Bitzani M, Papaioannou-Gaki G, Parlapani A, Thomareis O, et al. Early coagulation disorders after severe-burn injury: impact on mortality. Intensive Care Med. 2008;34(4):700\u20136. https:\/\/doi.org\/10.1007\/s00134-007-0976-5.","journal-title":"Intensive Care Med"},{"issue":"2","key":"3918_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/s0049-3848(97)00291-0","volume":"89","author":"A Garc\u00eda-Avello","year":"1998","unstructured":"Garc\u00eda-Avello A, Lorente JA, Cesar-Perez J, Garc\u00eda-Frade LJ, Alvarado R, Ar\u00e9valo JM, et al. Degree of hypercoagulability and hyperfibrinolysis is related to organ failure and prognosis after burn trauma. Thromb Res. 1998;89(2):59\u201364. https:\/\/doi.org\/10.1016\/s0049-3848(97)00291-0.","journal-title":"Thromb Res"},{"key":"3918_CR30","doi-asserted-by":"publisher","unstructured":"Aoki K, Aikawa N, Sekine K, Yamazaki M, Mimura T, Urano T et al. Elevation of plasma free PAI-1 levels as an integrated endothelial response to severe burns. Burns. 2001; 27(6): 569\u201375. https:\/\/doi.org\/10.1016\/s0305-4179(01)00011-0.","DOI":"10.1016\/s0305-4179(01)00011-0"},{"issue":"6","key":"3918_CR31","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1097\/TA.0b013e3182923193","volume":"74","author":"RP Lu","year":"2013","unstructured":"Lu RP, Ni A, Lin FC, Ortiz-Pujols SM, Adams SD, Monroe DM 3rd, et al. Major burn injury is not associated with acute traumatic coagulopathy. J Trauma Acute Care Surg. 2013;74(6):1474\u20139. https:\/\/doi.org\/10.1097\/TA.0b013e3182923193.","journal-title":"J Trauma Acute Care Surg"},{"issue":"6","key":"3918_CR32","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.burns.2013.02.010","volume":"39","author":"PB Sherren","year":"2013","unstructured":"Sherren PB, Hussey J, Martin R, Kundishora T, Parker M, Emerson B. Acute burn induced coagulopathy. Burns. 2013;39(6):1157\u201361. https:\/\/doi.org\/10.1016\/j.burns.2013.02.010.","journal-title":"Burns"},{"issue":"4","key":"3918_CR33","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1055\/s-0030-1254051","volume":"36","author":"G Lippi","year":"2010","unstructured":"Lippi G, Ippolito L, Cervellin G. Disseminated intravascular coagulation in burn injury. Semin Thromb Hemost. 2010;36(4):429\u201336. https:\/\/doi.org\/10.1055\/s-0030-1254051.","journal-title":"Semin Thromb Hemost"},{"key":"3918_CR34","doi-asserted-by":"publisher","unstructured":"Kowal-Vern A, Walenga JM, Hoppensteadt D, Gamelli RL. Prothrombin fragment 1.2 and modified antithrombin as predictors of disseminated intravascular coagulation and thrombotic risk in thermal injury. J Burn Care Res. 2013; 34(4): 459\u201364. https:\/\/doi.org\/10.1097\/BCR.0b013e3182700659.","DOI":"10.1097\/BCR.0b013e3182700659"},{"issue":"5","key":"3918_CR35","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/jth.13283","volume":"14","author":"GJ Glas","year":"2016","unstructured":"Glas GJ, Levi M, Schultz MJ. Coagulopathy and its management in patients with severe burns. JTH. 2016;14(5):865\u201374. https:\/\/doi.org\/10.1111\/jth.13283.","journal-title":"JTH"},{"issue":"1","key":"3918_CR36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13613-017-0244-y","volume":"7","author":"T Tagami","year":"2017","unstructured":"Tagami T, Matsui H, Moroe Y, Fukuda R, Shibata A, Tanaka C, et al. Antithrombin use and 28-day in-hospital mortality among severe-burn patients: an observational nationwide study. Ann Intensive Care. 2017;7(1):18. https:\/\/doi.org\/10.1186\/s13613-017-0244-y.","journal-title":"Ann Intensive Care"},{"issue":"2","key":"3918_CR37","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1160\/TH07-11-0684","volume":"100","author":"A Lavrentieva","year":"2008","unstructured":"Lavrentieva A, Kontakiotis T, Bitzani M, Parlapani A, Thomareis O, Scourtis H, et al. The efficacy of antithrombin administration in the acute phase of burn injury. Thromb Haemost. 2008;100(2):286\u201390. https:\/\/doi.org\/10.1160\/TH07-11-0684.","journal-title":"Thromb Haemost"},{"issue":"1","key":"3918_CR38","first-page":"29","volume":"20","author":"GJ Zayas","year":"2007","unstructured":"Zayas GJ, Bonilla AM, Saliba MJ. Heparin reduced mortality and sepsis in severely burned children. Ann Burns Fire Disasters. 2007;20(1):29\u201334.","journal-title":"Ann Burns Fire Disasters"},{"issue":"1","key":"3918_CR39","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/01.mpa.0000186248.89081.44","volume":"32","author":"K Maeda","year":"2006","unstructured":"Maeda K, Hirota M, Ichihara A, Ohmuraya M, Hashimoto D, Sugita H, et al. Applicability of disseminated intravascular coagulation parameters in the assessment of the severity of acute pancreatitis. Pancreas. 2006;32(1):87\u201392. https:\/\/doi.org\/10.1097\/01.mpa.0000186248.89081.44.","journal-title":"Pancreas"},{"issue":"6","key":"3918_CR40","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/s1499-3872(15)60376-9","volume":"14","author":"N Yang","year":"2015","unstructured":"Yang N, Zhang DL, Hao JY. Coagulopathy and the prognostic potential of D-dimer in hyperlipidemia-induced acute pancreatitis. Hepatobiliary Pancreat Dis Int. 2015;14(6):633\u201341. https:\/\/doi.org\/10.1016\/s1499-3872(15)60376-9.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"1","key":"3918_CR41","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/0300060516677929","volume":"45","author":"N Yang","year":"2017","unstructured":"Yang N, Hao J, Zhang D. Antithrombin III and D-dimer levels as indicators of disease severity in patients with hyperlipidaemic or biliary acute pancreatitis. J Inter Med Res. 2017;45(1):147\u201358. https:\/\/doi.org\/10.1177\/0300060516677929.","journal-title":"J Inter Med Res"},{"issue":"11","key":"3918_CR42","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/jhbp.787","volume":"27","author":"S Ikarashi","year":"2020","unstructured":"Ikarashi S, Kawai H, Hayashi K, Kohisa J, Sato T, Nozawa Y, et al. Risk factors for walled-off necrosis associated with severe acute pancreatitis: a multicenter retrospective observational study. J Hepatobiliary Pancreat Sci. 2020;27(11):887\u201395. https:\/\/doi.org\/10.1002\/jhbp.787.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"2","key":"3918_CR43","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1477-2574.2009.00038.x","volume":"11","author":"DJ Mole","year":"2009","unstructured":"Mole DJ, Olabi B, Robinson V, Garden OJ, Parks RW. Incidence of individual organ dysfunction in fatal acute pancreatitis: analysis of 1024 death records. HPB (Oxford). 2009;11(2):166\u201370. https:\/\/doi.org\/10.1111\/j.1477-2574.2009.00038.x.","journal-title":"HPB (Oxford)"},{"issue":"3","key":"3918_CR44","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s11239-014-1068-3","volume":"38","author":"A Murata","year":"2014","unstructured":"Murata A, Okamoto K, Mayumi T, Muramatsu K, Matsuda S. The recent time trend of outcomes of disseminated intravascular coagulation in Japan: an observational study based on a national administrative database. J Thromb Thrombolysis. 2014;38(3):364\u201371. https:\/\/doi.org\/10.1007\/s11239-014-1068-3.","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"3918_CR45","doi-asserted-by":"publisher","first-page":"321","DOI":"10.31662\/jmaj.2020-0023","volume":"3","author":"H Ohbe","year":"2020","unstructured":"Ohbe H, Yamakawa K, Taniguchi K, Morita K, Matsui H, Fushimi K, et al. Underlying disorders, clinical phenotypes, and treatment diversity among patients with disseminated intravascular coagulation. JMA. 2020;3(4):321\u20139. https:\/\/doi.org\/10.31662\/jmaj.2020-0023.","journal-title":"JMA"},{"issue":"1","key":"3918_CR46","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40560-021-00555-7","volume":"9","author":"M Egi","year":"2021","unstructured":"Egi M, Ogura H, Yatabe T, Atagi K, Inoue S, Iba T, et al. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020). J Intensive Care. 2021;9(1):53. https:\/\/doi.org\/10.1186\/s40560-021-00555-7.","journal-title":"J Intensive Care"},{"issue":"5","key":"3918_CR47","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.pan.2015.08.002","volume":"15","author":"T Eguchi","year":"2015","unstructured":"Eguchi T, Tsuji Y, Yamashita H, Fukuchi T, Kanamori A, Matsumoto K, et al. Efficacy of recombinant human soluble thrombomodulin in preventing walled-off necrosis in severe acute pancreatitis patients. Pancreatol. 2015;15(5):485\u201390. https:\/\/doi.org\/10.1016\/j.pan.2015.08.002.","journal-title":"Pancreatol"},{"issue":"4","key":"3918_CR48","doi-asserted-by":"publisher","first-page":"320","DOI":"10.5152\/tjar.2019.42709","volume":"47","author":"T Yano","year":"2019","unstructured":"Yano T, Taniguchi M, Shirasaka T, Tsuneyoshi I. Effectiveness of soluble recombinant human thrombomodulin in patients with severe acute pancreatitis complicated by disseminated intravascular coagulation. Turk J Anaesthesiol Reanim. 2019;47(4):320\u20136. https:\/\/doi.org\/10.5152\/tjar.2019.42709.","journal-title":"Turk J Anaesthesiol Reanim"},{"issue":"4","key":"3918_CR49","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1046\/j.1538-7836.2003.00194.x","volume":"1","author":"R Kerr","year":"2003","unstructured":"Kerr R, Newsome P, Germain L, Thomson E, Dawson P, Stirling D, et al. Effects of acute liver injury on blood coagulation. J Thromb Haemost. 2003;1(4):754\u20139. https:\/\/doi.org\/10.1046\/j.1538-7836.2003.00194.x.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"3918_CR50","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0049-3848(95)00157-m","volume":"80","author":"M Arai","year":"1995","unstructured":"Arai M, Mochida S, Ohno A, Ogata I, Obama H, Maruyama I, et al. Blood coagulation equilibrium in rat liver microcirculation as evaluated by endothelial cell thrombomodulin and macrophage tissue factor. Thromb Res. 1995;80(2):113\u201323. https:\/\/doi.org\/10.1016\/0049-3848(95)00157-m.","journal-title":"Thromb Res"},{"issue":"6","key":"3918_CR51","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/s0049-3848(97)00038-8","volume":"85","author":"F Yamanobe","year":"1997","unstructured":"Yamanobe F, Mochida S, Ohno A, Ishikawa K, Fujiwara K. Recombinant human tissue factor pathway inhibitor as a possible anticoagulant targeting hepatic sinusoidal walls. Thromb Res. 1997;85(6):493\u2013501. https:\/\/doi.org\/10.1016\/s0049-3848(97)00038-8.","journal-title":"Thromb Res"},{"issue":"5","key":"3918_CR52","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1002\/hep.510290533","volume":"29","author":"S Mochida","year":"1999","unstructured":"Mochida S, Arai M, Ohno A, Yamanobe F, Ishikawa K, Matsui A, et al. Deranged blood coagulation equilibrium as a factor of massive liver necrosis following endotoxin administration in partially hepatectomized rats. Hepatology. 1999;29(5):1532\u201340. https:\/\/doi.org\/10.1002\/hep.510290533.","journal-title":"Hepatology"},{"issue":"2","key":"3918_CR53","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1053\/jhep.1996.v23.pm0008591859","volume":"23","author":"S Mochida","year":"1996","unstructured":"Mochida S, Ohno A, Arai M, Tamatani T, Miyasaka M, Fujiwara K. Role of adhesion molecules in the development of massive hepatic necrosis in rats. Hepatology. 1996;23(2):320\u20138. https:\/\/doi.org\/10.1053\/jhep.1996.v23.pm0008591859.","journal-title":"Hepatology"},{"issue":"6","key":"3918_CR54","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s00535-017-1394-2","volume":"53","author":"M Nakao","year":"2018","unstructured":"Nakao M, Nakayama N, Uchida Y, Tomiya T, Ido A, Sakaida I, et al. Nationwide survey for acute liver failure and late-onset hepatic failure in Japan. J Gastroenterol. 2018;53(6):752\u201369. https:\/\/doi.org\/10.1007\/s00535-017-1394-2.","journal-title":"J Gastroenterol"},{"key":"3918_CR55","unstructured":"Mochida S, Nakayama N. Acute Liver Failure and Delayed Liver Failure (LOHF) in Japan (2020): 2021 National Survey. Ministry of Health, Labour and Welfare, Grant-in-Aid for Scientific Research (Intractable Disease Policy Research Project), \u201cResearch and Study on Intractable Liver and Biliary Diseases\u201d. 2021."},{"key":"3918_CR56","doi-asserted-by":"publisher","unstructured":"Asakura H, Takahashi H, Uchiyama T, Eguchi Y, Okamoto K, Kawasugi K. Japanese Society of Thrombosis and Haemostasis DIC Diagnostic Criteria, 2017 Edition. Jpn J Thromb Hemost. 2017; 28(3): 369\u201391. https:\/\/doi.org\/10.2491\/jjsth.28.369.","DOI":"10.2491\/jjsth.28.369"},{"issue":"10","key":"3918_CR57","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.3748\/wjg.14.1549","volume":"14","author":"A Spadaro","year":"2008","unstructured":"Spadaro A, Tortorella V, Morace C, Fortiguerra A, Composto P, Bonfiglio C, et al. High circulating D-dimers are associated with ascites and hepatocellular carcinoma in liver cirrhosis. World J Gastroenterol. 2008;14(10):1549\u201352. https:\/\/doi.org\/10.3748\/wjg.14.1549.","journal-title":"World J Gastroenterol"},{"key":"3918_CR58","unstructured":"Ministry of Health Law, Research Group for Intractable Liver and Biliary Diseases. 2017."},{"issue":"3","key":"3918_CR59","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/s0168-8278(05)80213-2","volume":"17","author":"PG Langley","year":"1993","unstructured":"Langley PG, Hughes RD, Forbes A, Keays R, Williams R. Controlled trial of antithrombin III supplementation in fulminant hepatic failure. J Hepatol. 1993;17(3):326\u201331. https:\/\/doi.org\/10.1016\/s0168-8278(05)80213-2.","journal-title":"J Hepatol"},{"issue":"4","key":"3918_CR60","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/bf02779211","volume":"23","author":"K Fujiwara","year":"1988","unstructured":"Fujiwara K, Okita K, Akamatsu K, Abe H, Tameda Y, Sakai T, et al. Antithrombin III concentrate in the treatment of fulminant hepatic failure. Gastroenterol Jpn. 1988;23(4):423\u20137. https:\/\/doi.org\/10.1007\/bf02779211.","journal-title":"Gastroenterol Jpn"},{"key":"3918_CR61","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2147\/jbm.S273047","volume":"13","author":"O Erez","year":"2022","unstructured":"Erez O, Othman M, Rabinovich A, Leron E, Gotsch F, Thachil J. DIC in Pregnancy - pathophysiology, clinical characteristics, diagnostic scores, and treatments. J Blood Med. 2022;13:21\u201344. https:\/\/doi.org\/10.2147\/jbm.S273047.","journal-title":"J Blood Med"},{"issue":"9","key":"3918_CR62","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1111\/jog.14875","volume":"47","author":"M Morikawa","year":"2021","unstructured":"Morikawa M, Nii M, Nakabayashi Y, Itakura A, Kobayashi T, Adachi T. Capacity of Japanese institutions to manage obstetrical disseminated intravascular coagulation in 2018: a national surveillance questionnaire and retrospective cohort study. J Obstet Gynaecol Res. 2021;47(9):3159\u201370. https:\/\/doi.org\/10.1111\/jog.14875.","journal-title":"J Obstet Gynaecol Res"},{"issue":"4","key":"3918_CR63","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ajog.2015.03.054","volume":"213","author":"O Erez","year":"2015","unstructured":"Erez O, Mastrolia SA, Thachil J. Disseminated intravascular coagulation in pregnancy: insights in pathophysiology, diagnosis and management. Am J Obstet Gynecol. 2015;213(4):452\u201363. https:\/\/doi.org\/10.1016\/j.ajog.2015.03.054.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"3918_CR64","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1055\/s-0030-1254049","volume":"36","author":"M Montagnana","year":"2010","unstructured":"Montagnana M, Franchi M, Danese E, Gotsch F, Guidi GC. Disseminated intravascular coagulation in obstetric and gynecologic disorders. Semin Thromb Hemost. 2010;36(4):404\u201318. https:\/\/doi.org\/10.1055\/s-0030-1254049.","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"3918_CR65","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1097\/aog.0000000000001110","volume":"126","author":"FG Cunningham","year":"2015","unstructured":"Cunningham FG, Nelson DB. Disseminated intravascular coagulation syndromes in obstetrics. Obstet Gynecol. 2015;126(5):999\u20131011. https:\/\/doi.org\/10.1097\/aog.0000000000001110.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"3918_CR66","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/aogs.14500","volume":"102","author":"K Harris","year":"2023","unstructured":"Harris K, Proctor LK, Shinar S, Philippopoulos E, Yudin MH, Murphy KE. Outcomes and management of pregnancy and puerperal group A streptococcal infections: a systematic review. Acta Obstet Gynecol Scand. 2023;102(2):138\u201357. https:\/\/doi.org\/10.1111\/aogs.14500.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"7","key":"3918_CR67","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1080\/14767058.2016.1189897","volume":"30","author":"K Haram","year":"2017","unstructured":"Haram K, Mortensen JH, Mastrolia SA, Erez O. Disseminated intravascular coagulation in the HELLP syndrome: how much do we really know? J Matern Fetal Neonatal Med. 2017;30(7):779\u201388. https:\/\/doi.org\/10.1080\/14767058.2016.1189897.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"17","key":"3918_CR68","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1080\/14767058.2020.1818200","volume":"35","author":"R Gomez-Tolub","year":"2022","unstructured":"Gomez-Tolub R, Rabinovich A, Kachko E, Benshalom-Tirosh N, Tirosh D, Thachil J, et al. Placental abruption as a trigger of DIC in women with HELLP syndrome: a population-based study. J Matern Fetal Neonatal Med. 2022;35(17):3259\u201369. https:\/\/doi.org\/10.1080\/14767058.2020.1818200.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"7","key":"3918_CR69","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1080\/14767058.2020.1754790","volume":"35","author":"JJ Byrne","year":"2022","unstructured":"Byrne JJ, Seasely A, Nelson DB, McIntire DD, Cunningham FG. Comparing acute fatty liver of pregnancy from hemolysis, elevated liver enzymes, and low platelets syndrome. J Matern Fetal Neonatal Med. 2022;35(7):1352\u201362. https:\/\/doi.org\/10.1080\/14767058.2020.1754790.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"3","key":"3918_CR70","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1053\/j.semperi.2009.02.004","volume":"33","author":"BM Sibai","year":"2009","unstructured":"Sibai BM. Imitators of severe pre-eclampsia. Semin Perinatol. 2009;33(3):196\u2013205. https:\/\/doi.org\/10.1053\/j.semperi.2009.02.004.","journal-title":"Semin Perinatol"},{"issue":"5","key":"3918_CR71","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1055\/s-0037-1616068","volume":"86","author":"FB Taylor Jr","year":"2001","unstructured":"Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86(5):1327\u201330.","journal-title":"Thromb Haemost"},{"issue":"4","key":"3918_CR72","doi-asserted-by":"publisher","first-page":"e93240","DOI":"10.1371\/journal.pone.0093240","volume":"9","author":"O Erez","year":"2014","unstructured":"Erez O, Novack L, Beer-Weisel R, Dukler D, Press F, Zlotnik A, et al. DIC score in pregnant women\u2013a population-based modification of the International Society on Thrombosis and Hemostasis score. PLoS ONE. 2014;9(4):e93240. https:\/\/doi.org\/10.1371\/journal.pone.0093240.","journal-title":"PLoS ONE"},{"issue":"6","key":"3918_CR73","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1111\/jog.12426","volume":"40","author":"T Kobayashi","year":"2014","unstructured":"Kobayashi T. Obstetrical disseminated intravascular coagulation score. J Obstet Gynaecol Res. 2014;40(6):1500\u20136. https:\/\/doi.org\/10.1111\/jog.12426.","journal-title":"J Obstet Gynaecol Res"},{"key":"3918_CR74","unstructured":"Itakura A, Serizawa M, Takeda J, Takeda Y, Futai T, Hyodo H et al. Disseminated intravascular coagulation syndrome (DIC) in obstetrics; Provisional obstetric DIC diagnostic criteria. JJ Obstet Gynecol Neonat Hematol. 2023; 32(2): 43\u20139. http:\/\/search.jamas.or.jp\/link\/ui\/2023153428(in Japanese)"},{"issue":"1","key":"3918_CR75","doi-asserted-by":"publisher","first-page":"17677","DOI":"10.1038\/s41598-024-68298-","volume":"14","author":"M Morikawa","year":"2024","unstructured":"Morikawa M, Takeda Y, Matsunaga S, Makino S, Eto E, Serizawa M, et al. Effectiveness, reliability, and validity of new Japanese diagnostic criteria for obstetrical disseminated intravascular coagulation. Sci Rep. 2024;14(1):17677. https:\/\/doi.org\/10.1038\/s41598-024-68298-.","journal-title":"Sci Rep"},{"issue":"4","key":"3918_CR76","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/bja\/aeu444","volume":"114","author":"AJ Wikkels\u00f8","year":"2015","unstructured":"Wikkels\u00f8 AJ, Edwards HM, Afshari A, Stensballe J, Langhoff-Roos J, Albrechtsen C, et al. Pre-emptive treatment with fibrinogen concentrate for post-partum haemorrhage: randomized controlled trial. Br J Anaesth. 2015;114(4):623\u201333. https:\/\/doi.org\/10.1093\/bja\/aeu444.","journal-title":"Br J Anaesth"},{"issue":"3","key":"3918_CR77","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/bja\/aex181","volume":"119","author":"PW Collins","year":"2017","unstructured":"Collins PW, Cannings-John R, Bruynseels D, Mallaiah S, Dick J, Elton C, et al. Viscoelastometric-guided early fibrinogen concentrate replacement during post-partum haemorrhage: OBS2, a double-blind randomized controlled trial. Br J Anaesth. 2017;119(3):411\u201321. https:\/\/doi.org\/10.1093\/bja\/aex181.","journal-title":"Br J Anaesth"},{"issue":"11","key":"3918_CR78","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1111\/1471-0528.16699","volume":"128","author":"AS Ducloy-Bouthors","year":"2021","unstructured":"Ducloy-Bouthors AS, Mercier FJ, Grouin JM, Bayoumeu F, Corouge J, Le Gouez A, et al. Early and systematic administration of fibrinogen concentrate in post-partum haemorrhage following vaginal delivery: the FIDEL randomised controlled trial. BJOG. 2021;128(11):1814\u201323. https:\/\/doi.org\/10.1111\/1471-0528.16699.","journal-title":"BJOG"},{"issue":"2","key":"3918_CR79","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/anae.12859","volume":"70","author":"S Mallaiah","year":"2015","unstructured":"Mallaiah S, Barclay P, Harrod I, Chevannes C, Bhalla A. Introduction of an algorithm for ROTEM-guided fibrinogen concentrate administration in major obstetric haemorrhage. Anaesthesia. 2015;70(2):166\u201375. https:\/\/doi.org\/10.1111\/anae.12859.","journal-title":"Anaesthesia"},{"issue":"8","key":"3918_CR80","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/anae.14628","volume":"74","author":"H McNamara","year":"2019","unstructured":"McNamara H, Kenyon C, Smith R, Mallaiah S, Barclay P. Four years\u2019 experience of a ROTEM(\u00ae) -guided algorithm for treatment of coagulopathy in obstetric haemorrhage. Anaesthesia. 2019;74(8):984\u201391. https:\/\/doi.org\/10.1111\/anae.14628.","journal-title":"Anaesthesia"},{"key":"3918_CR81","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijoa.2017.03.005","volume":"32","author":"S Seto","year":"2017","unstructured":"Seto S, Itakura A, Okagaki R, Suzuki M, Ishihara O. An algorithm for the management of coagulopathy from post-partum hemorrhage, using fibrinogen concentrate as first-line therapy. Int J Obstet Anesth. 2017;32:11\u20136. https:\/\/doi.org\/10.1016\/j.ijoa.2017.03.005.","journal-title":"Int J Obstet Anesth"},{"issue":"5","key":"3918_CR82","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/j.1365-3148.2012.01178.x","volume":"22","author":"S Ahmed","year":"2012","unstructured":"Ahmed S, Harrity C, Johnson S, Varadkar S, McMorrow S, Fanning R, et al. The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage\u2013an observational study. Transfus Med. 2012;22(5):344\u20139. https:\/\/doi.org\/10.1111\/j.1365-3148.2012.01178.x.","journal-title":"Transfus Med"},{"key":"3918_CR83","doi-asserted-by":"publisher","first-page":"46749","DOI":"10.1038\/srep46749","volume":"7","author":"S Matsunaga","year":"2017","unstructured":"Matsunaga S, Takai Y, Nakamura E, Era S, Ono Y, Yamamoto K, et al. The clinical efficacy of fibrinogen concentrate in massive obstetric haemorrhage with hypofibrinogenaemia. Sci Rep. 2017;7:46749. https:\/\/doi.org\/10.1038\/srep46749.","journal-title":"Sci Rep"},{"issue":"10084","key":"3918_CR84","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/s0140-6736(17)30638-4","volume":"389","author":"Effect of early tranexamic acid administration on mortality","year":"2017","unstructured":"Effect of early tranexamic acid administration on mortality. hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017;389(10084):2105\u201316. https:\/\/doi.org\/10.1016\/s0140-6736(17)30638-4.","journal-title":"Lancet"},{"issue":"1","key":"3918_CR85","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/s2214-109x(17)30428-x","volume":"6","author":"JP Vogel","year":"2018","unstructured":"Vogel JP, Oladapo OT, Dowswell T, G\u00fclmezoglu AM. Updated WHO recommendation on intravenous tranexamic acid for the treatment of post-partum haemorrhage. Lancet Glob Health. 2018;6(1):e18\u20139. https:\/\/doi.org\/10.1016\/s2214-109x(17)30428-x.","journal-title":"Lancet Glob Health"},{"issue":"2","key":"3918_CR86","doi-asserted-by":"publisher","first-page":"R117","DOI":"10.1186\/cc10143","volume":"15","author":"AS Ducloy-Bouthors","year":"2011","unstructured":"Ducloy-Bouthors AS, Jude B, Duhamel A, Broisin F, Huissoud C, Keita-Meyer H, et al. High-dose tranexamic acid reduces blood loss in post-partum haemorrhage. Crit Care. 2011;15(2):R117. https:\/\/doi.org\/10.1186\/cc10143.","journal-title":"Crit Care"},{"issue":"4","key":"3918_CR87","doi-asserted-by":"publisher","first-page":"348","DOI":"10.4103\/0300-1652.137228","volume":"55","author":"F Sahhaf","year":"2014","unstructured":"Sahhaf F, Abbasalizadeh S, Ghojazadeh M, Velayati A, Khandanloo R, Saleh P, et al. Comparison effect of intravenous tranexamic acid and misoprostol for post-partum haemorrhage. Niger Med J. 2014;55(4):348\u201353. https:\/\/doi.org\/10.4103\/0300-1652.137228.","journal-title":"Niger Med J"},{"issue":"1","key":"3918_CR88","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12978-020-0887-2","volume":"17","author":"A Diop","year":"2020","unstructured":"Diop A, Abbas D, Ngoc NTN, Martin R, Razafi A, Tuyet HTD, et al. A double-blind, randomized controlled trial to explore oral tranexamic acid as adjunct for the treatment for post-partum hemorrhage. Reprod Health. 2020;17(1):34. https:\/\/doi.org\/10.1186\/s12978-020-0887-2.","journal-title":"Reprod Health"},{"issue":"6","key":"3918_CR89","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.bja.2022.08.033","volume":"129","author":"AS Ducloy-Bouthors","year":"2022","unstructured":"Ducloy-Bouthors AS, Gilliot S, Kyheng M, Faraoni D, Turbelin A, Keita-Meyer H, et al. Tranexamic acid dose-response relationship for antifibrinolysis in post-partum haemorrhage during Caesarean delivery: TRACES, a double-blind, placebo-controlled, multicentre, dose-ranging biomarker study. Br J Anaesth. 2022;129(6):937\u201345. https:\/\/doi.org\/10.1016\/j.bja.2022.08.033.","journal-title":"Br J Anaesth"},{"issue":"6","key":"3918_CR90","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00228-020-03064-y","volume":"77","author":"D St\u00e4mpfli","year":"2021","unstructured":"St\u00e4mpfli D, Weiler S, Weiniger CF, Burden AM, Heesen M. Renal ischemic adverse drug events related to tranexamic acid in women of child-bearing age: an analysis of pharmacovigilance data. Eur J Clin Pharmacol. 2021;77(6):913\u20139. https:\/\/doi.org\/10.1007\/s00228-020-03064-y.","journal-title":"Eur J Clin Pharmacol"},{"issue":"17","key":"3918_CR91","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1056\/NEJMoa2028788","volume":"384","author":"L Sentilhes","year":"2021","unstructured":"Sentilhes L, S\u00e9nat MV, Le Lous M, Winer N, Rozenberg P, Kayem G, et al. Tranexamic acid for the prevention of blood loss after cesarean delivery. N Eng J Med. 2021;384(17):1623\u201334. https:\/\/doi.org\/10.1056\/NEJMoa2028788.","journal-title":"N Eng J Med"},{"key":"3918_CR92","doi-asserted-by":"publisher","unstructured":"Sentilhes L, Madar H, Le Lous M, S\u00e9nat MV, Winer N, Rozenberg P et al. Tranexamic acid for the prevention of blood loss after cesarean among women with twins: a secondary analysis of the TRAnexamic Acid for Preventing Post-partum Hemorrhage Following a Cesarean Delivery randomized clinical trial. Am J Obstet Gynecol.. 2022; 227(6): 889.e1-.e17. https:\/\/doi.org\/10.1016\/j.ajog.2022.06.019.","DOI":"10.1016\/j.ajog.2022.06.019"},{"issue":"15","key":"3918_CR93","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1056\/NEJMoa2207419","volume":"388","author":"LD Pacheco","year":"2023","unstructured":"Pacheco LD, Clifton RG, Saade GR, Weiner SJ, Parry S, Thorp JM Jr, et al. Tranexamic acid to prevent obstetrical hemorrhage after cesarean delivery. N Eng J Med. 2023;388(15):1365\u201375. https:\/\/doi.org\/10.1056\/NEJMoa2207419.","journal-title":"N Eng J Med"},{"issue":"Suppl 1","key":"3918_CR94","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/aogs.14103","volume":"100","author":"A Schwickert","year":"2021","unstructured":"Schwickert A, van Beekhuizen HJ, Bertholdt C, Fox KA, Kayem G, Morel O, et al. Association of peripartum management and high maternal blood loss at cesarean delivery for placenta accreta spectrum (PAS): a multinational database study. Acta Obstet Gynecol Scand. 2021;100(Suppl 1):29\u201340. https:\/\/doi.org\/10.1111\/aogs.14103.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"3918_CR95","doi-asserted-by":"publisher","unstructured":"Mart\u00ed-Carvajal AJ, Comuni\u00e1n-Carrasco G, Pe\u00f1a-Mart\u00ed GE. Haematological interventions for treating disseminated intravascular coagulation during pregnancy and post-partum. Cochrane Database Sys Rev. 2011; 2011(3): Cd008577. https:\/\/doi.org\/10.1002\/14651858.CD008577.pub2.","DOI":"10.1002\/14651858.CD008577.pub2"},{"issue":"5","key":"3918_CR96","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/1471-0528.16938","volume":"129","author":"Y Iwasaki","year":"2022","unstructured":"Iwasaki Y, Ohbe H, Shigemi D, Fushimi K, Yasunaga H. Effect of antithrombin III among patients with disseminated intravascular coagulation in obstetrics: a nationwide observational study in Japan. BJOG. 2022;129(5):805\u201311. https:\/\/doi.org\/10.1111\/1471-0528.16938.","journal-title":"BJOG"},{"key":"3918_CR97","unstructured":"Maki M, Terao T, Ikenoue K, Fujimoto S, Kudo R, Nishitani I et al. Therapeutic efficacy of antithrombin III concentrate in obstetric DIC: results of a multicenter study. JJ Obstet Gynecol Neonat Hematol. 1994; 4(1): 37\u201349. http:\/\/search.jamas.or.jp\/link\/ui\/1994184524 (in Japanese)"},{"key":"3918_CR98","doi-asserted-by":"publisher","unstructured":"Maki M, Terao T, Ikenoue T, Takemura T, Sekiba K, Shirakawa K et al. Clinical evaluation of antithrombin III concentrate (BI 6.013) for disseminated intravascular coagulation in obstetrics. Well-controlled multicenter trial. Gynecol Obstet Invest. 1987; 23(4): 230\u201340. https:\/\/doi.org\/10.1159\/000298866.","DOI":"10.1159\/000298866"},{"issue":"6","key":"3918_CR99","doi-asserted-by":"publisher","first-page":"763","DOI":"10.11406\/rinketsu.31.763(inJapanese)","volume":"31","author":"M Murata","year":"1990","unstructured":"Murata M, Hayakawa M, Goto K, Isobe K, Matuura T, Hirano H, et al. Anticoagulant therapy in obstetrical disorders. JJ Clin Hematol. 1990;31(6):763\u20138. https:\/\/doi.org\/10.11406\/rinketsu.31.763(inJapanese).","journal-title":"JJ Clin Hematol"},{"key":"3918_CR100","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.thromres.2017.08.017","volume":"159","author":"T Kobayashi","year":"2017","unstructured":"Kobayashi T, Kajiki M, Nihashi K, Honda G. Surveillance of the safety and efficacy of recombinant human soluble thrombomodulin in patients with obstetrical disseminated intravascular coagulation. Thromb Res. 2017;159:109\u201315. https:\/\/doi.org\/10.1016\/j.thromres.2017.08.017.","journal-title":"Thromb Res"},{"issue":"5","key":"3918_CR101","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1177\/1076029612443305","volume":"19","author":"J Sugawara","year":"2013","unstructured":"Sugawara J, Suenaga K, Hoshiai T, Sato T, Nishigori H, Nagase S, et al. Efficacy of recombinant human soluble thrombomodulin in severe post-partum hemorrhage with disseminated intravascular coagulation. Clin Appl Thromb Hemost. 2013;19(5):557\u201361. https:\/\/doi.org\/10.1177\/1076029612443305.","journal-title":"Clin Appl Thromb Hemost"},{"key":"3918_CR102","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/s13054-015-1086-3","volume":"19","author":"M Yoshihara","year":"2015","unstructured":"Yoshihara M, Uno K, Tano S, Mayama M, Ukai M, Kondo S, et al. The efficacy of recombinant human soluble thrombomodulin for obstetric disseminated intravascular coagulation: a retrospective study. Crit Care. 2015;19:369. https:\/\/doi.org\/10.1186\/s13054-015-1086-3.","journal-title":"Crit Care"},{"issue":"7","key":"3918_CR103","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1111\/j.1399-6576.2007.01323.x","volume":"51","author":"J Ahonen","year":"2007","unstructured":"Ahonen J, Jokela R, Korttila K. An open non-randomized study of recombinant activated factor VII in major post-partum haemorrhage. Acta Anaesthesiol Scand. 2007;51(7):929\u201336. https:\/\/doi.org\/10.1111\/j.1399-6576.2007.01323.x.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"10","key":"3918_CR104","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1080\/00016340701619324","volume":"86","author":"N Hossain","year":"2007","unstructured":"Hossain N, Shansi T, Haider S, Soomro N, Khan NH, Memon GU, et al. Use of recombinant activated factor VII for massive post-partum hemorrhage. Acta Obstet Gynecol Scand. 2007;86(10):1200\u20136. https:\/\/doi.org\/10.1080\/00016340701619324.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"3918_CR105","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s12185-011-0974-9","volume":"95","author":"T Kobayashi","year":"2012","unstructured":"Kobayashi T, Nakabayashi M, Yoshioka A, Maeda M, Ikenoue T. Recombinant activated factor VII (rFVIIa\/NovoSeven\u00ae) in the management of severe post-partum haemorrhage: initial report of a multicentre case series in Japan. Int J Hematol. 2012;95(1):57\u201363. https:\/\/doi.org\/10.1007\/s12185-011-0974-9.","journal-title":"Int J Hematol"},{"issue":"4","key":"3918_CR106","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/jth.12844","volume":"13","author":"G Lavigne-Lissalde","year":"2015","unstructured":"Lavigne-Lissalde G, Aya AG, Mercier FJ, Roger-Christoph S, Chauleur C, Morau E, et al. Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory post-partum hemorrhage: a multicenter, randomized, open controlled trial. J Thromb Haemost. 2015;13(4):520\u20139. https:\/\/doi.org\/10.1111\/jth.12844.","journal-title":"J Thromb Haemost"},{"issue":"8","key":"3918_CR107","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1111\/jog.12712","volume":"41","author":"M Murakami","year":"2015","unstructured":"Murakami M, Kobayashi T, Kubo T, Hata T, Takeda S, Masuzaki H. Experience with recombinant activated factor VII for severe post-partum hemorrhage in Japan, investigated by Perinatology Committee, Japan Society of Obstetrics and Gynecology. J Obstet Gynaecol Res. 2015;41(8):1161\u20138. https:\/\/doi.org\/10.1111\/jog.12712.","journal-title":"J Obstet Gynaecol Res"},{"issue":"4","key":"3918_CR108","doi-asserted-by":"publisher","first-page":"333","DOI":"10.4266\/kjccm.2016.00787","volume":"32","author":"SC Park","year":"2017","unstructured":"Park SC, Yeom SR, Han SK, Jo YM, Kim HB. Recombinant activated factor VII as a second line treatment for post-partum hemorrhage. Korean J Crit Care Med. 2017;32(4):333\u20139. https:\/\/doi.org\/10.4266\/kjccm.2016.00787.","journal-title":"Korean J Crit Care Med"},{"issue":"2","key":"3918_CR109","doi-asserted-by":"publisher","first-page":"87","DOI":"10.7889\/hct-20-026","volume":"10","author":"H Kimura","year":"2021","unstructured":"Kimura H. Chronic active EB virous infection. J Hematopoiet Cell Transpl. 2021;10(2):87\u201393. https:\/\/doi.org\/10.7889\/hct-20-026.","journal-title":"J Hematopoiet Cell Transpl"},{"issue":"10","key":"3918_CR110","doi-asserted-by":"publisher","first-page":"e30158","DOI":"10.7759\/cureus.30158","volume":"14","author":"Y Alotaibi","year":"2022","unstructured":"Alotaibi Y, Albogami M, Alsaedy A, Khubrani R, Al AB. A lethal manifestation of chronic active epstein-barr virus infection: a case report. Cureus. 2022;14(10):e30158. https:\/\/doi.org\/10.7759\/cureus.30158.","journal-title":"Cureus"},{"issue":"4","key":"3918_CR111","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1086\/367988","volume":"187","author":"H Kimura","year":"2003","unstructured":"Kimura H, Morishima T, Kanegane H, Ohga S, Hoshino Y, Maeda A, et al. Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis. 2003;187(4):527\u201333. https:\/\/doi.org\/10.1086\/367988.","journal-title":"J Infect Dis"},{"key":"3918_CR112","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.3389\/fimmu.2017.01867","volume":"8","author":"H Kimura","year":"2017","unstructured":"Kimura H, Cohen JI. Chronic active epstein-barr virus disease. Front Immunol. 2017;8:1867. https:\/\/doi.org\/10.3389\/fimmu.2017.01867.","journal-title":"Front Immunol"},{"key":"3918_CR113","unstructured":"Guidelines for the Treatment of Chronic Active EV Virus Infection and Related Diseases. https:\/\/www.jspid.jp\/wp-content\/uploads\/2021\/10\/guideline_EB_virus.pdf."},{"issue":"3","key":"3918_CR114","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s12098-013-1145-1","volume":"81","author":"M Yamamoto","year":"2014","unstructured":"Yamamoto M, Hori T, Hatakeyama N, Igarashi K, Inazawa N, Tsutsumi H, et al. Use of recombinant thrombomodulin in disseminated intravascular coagulation complicated hemophagocytic lymphohistiocytosis. Indian J Pediatr. 2014;81(3):288\u201391. https:\/\/doi.org\/10.1007\/s12098-013-1145-1.","journal-title":"Indian J Pediatr"},{"issue":"1","key":"3918_CR115","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/ccr3.1301","volume":"6","author":"K Saevels","year":"2018","unstructured":"Saevels K, Robert D, Van den Broeck S, Malfait R, Gadisseur A, Jorens P, et al. EBV-associated hemophagocytic lymphohistiocytosis complicated by severe coagulation disorders and opportunistic infections: case report of a survivor. Clin Case Rep. 2018;6(1):115\u20138. https:\/\/doi.org\/10.1002\/ccr3.1301.","journal-title":"Clin Case Rep"},{"issue":"9768","key":"3918_CR116","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/s0140-6736(10)60667-8","volume":"377","author":"H Feldmann","year":"2011","unstructured":"Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet. 2011;377(9768):849\u201362. https:\/\/doi.org\/10.1016\/s0140-6736(10)60667-8.","journal-title":"Lancet"},{"key":"3918_CR117","doi-asserted-by":"publisher","first-page":"105657","DOI":"10.1016\/j.micpath.2022.105657","volume":"169","author":"O Gholizadeh","year":"2022","unstructured":"Gholizadeh O, Jafari MM, Zoobinparan R, Yasamineh S, Tabatabaie R, Akbarzadeh S, et al. Recent advances in treatment Crimean-Congo hemorrhagic fever virus: a concise overview. Microb Pathog. 2022;169:105657. https:\/\/doi.org\/10.1016\/j.micpath.2022.105657.","journal-title":"Microb Pathog"},{"key":"3918_CR118","unstructured":"Hunter N, Rathish B. Marburg Fever. StatPearls. Treasure Island (FL): StatPearls Publishing 2022 Jan."},{"key":"3918_CR119","doi-asserted-by":"publisher","first-page":"j2986","DOI":"10.1136\/bmj.j2986","volume":"358","author":"C Houlihan","year":"2017","unstructured":"Houlihan C, Behrens R. Lassa fever Bmj. 2017;358:j2986. https:\/\/doi.org\/10.1136\/bmj.j2986.","journal-title":"Lassa fever Bmj"},{"key":"3918_CR120","doi-asserted-by":"publisher","first-page":"1040093","DOI":"10.3389\/fmicb.2022.1040093","volume":"13","author":"L Fl\u00f3rez-\u00c1lvarez","year":"2022","unstructured":"Fl\u00f3rez-\u00c1lvarez L, de Souza EE, Botosso VF, de Oliveira DBL, Ho PL, Taborda CP, et al. Hemorrhagic fever viruses: pathogenesis, therapeutics, and emerging and re-emerging potential. Front Microbiol. 2022;13:1040093. https:\/\/doi.org\/10.3389\/fmicb.2022.1040093.","journal-title":"Front Microbiol"},{"issue":"2","key":"3918_CR121","doi-asserted-by":"publisher","first-page":"83","DOI":"10.5152\/eajm.2011.19","volume":"43","author":"Z Ozkurt","year":"2011","unstructured":"Ozkurt Z, Ozden K, Kiki I, Usanmaz M. Prognostic significance of antithrombin activity in patients with crimean-congo hemorrhagic Fever. Eurasian J Med. 2011;43(2):83\u20136. https:\/\/doi.org\/10.5152\/eajm.2011.19.","journal-title":"Eurasian J Med"},{"issue":"2","key":"3918_CR122","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","volume":"383","author":"M Ackermann","year":"2020","unstructured":"Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383(2):120\u20138. https:\/\/doi.org\/10.1056\/NEJMoa2015432.","journal-title":"N Engl J Med"},{"issue":"10","key":"3918_CR123","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1111\/jth.15808","volume":"20","author":"S Schulman","year":"2022","unstructured":"Schulman S, Sholzberg M, Spyropoulos AC, Zarychanski R, Resnick HE, Bradbury CA, et al. ISTH guidelines for antithrombotic treatment in COVID-19. J Thromb Haemost. 2022;20(10):2214\u201325. https:\/\/doi.org\/10.1111\/jth.15808.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"3918_CR124","doi-asserted-by":"publisher","first-page":"101515","DOI":"10.1016\/j.berh.2020.101515","volume":"34","author":"G Griffin","year":"2020","unstructured":"Griffin G, Shenoi S, Hughes GC. Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy. Best Pract Res Clin Rheumatol. 2020;34(4):101515. https:\/\/doi.org\/10.1016\/j.berh.2020.101515.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"3918_CR125","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3947\/ic.2018.0203","volume":"53","author":"B Kim","year":"2021","unstructured":"Kim B, Choi YW, Pai H, Kim J. A case of human immunodeficiency virus-triggered hemophagocytic lymphohistocytosis presenting with severe bleeding tendency. Infect Chemother. 2021;53(4):802\u20137. https:\/\/doi.org\/10.3947\/ic.2018.0203.","journal-title":"Infect Chemother"},{"issue":"4","key":"3918_CR126","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1177\/0883073814558119","volume":"30","author":"I Kuki","year":"2015","unstructured":"Kuki I, Shiomi M, Okazaki S, Kawawaki H, Tomiwa K, Amo K, et al. Characteristic neuroradiologic features in hemorrhagic shock and encephalopathy syndrome. J Child Neurol. 2015;30(4):468\u201375. https:\/\/doi.org\/10.1177\/0883073814558119.","journal-title":"J Child Neurol"},{"issue":"11","key":"3918_CR127","doi-asserted-by":"publisher","first-page":"e1002369","DOI":"10.1371\/journal.ppat.1002369","volume":"7","author":"B Xu","year":"2011","unstructured":"Xu B, Liu L, Huang X, Ma H, Zhang Y, Du Y, et al. Metagenomic analysis of fever, thrombocytopenia and leukopenia syndrome (FTLS) in Henan Province, China: discovery of a new bunyavirus. PLoS Pathog. 2011;7(11):e1002369. https:\/\/doi.org\/10.1371\/journal.ppat.1002369.","journal-title":"PLoS Pathog"},{"issue":"2","key":"3918_CR128","doi-asserted-by":"publisher","first-page":"466","DOI":"10.4269\/ajtmh.17-0576","volume":"99","author":"M Noguchi","year":"2018","unstructured":"Noguchi M, Oshita S, Yamazoe N, Miyazaki M, Takemura YC. Important clinical features of japanese spotted fever. Am J Trop Med Hyg. 2018;99(2):466\u20139. https:\/\/doi.org\/10.4269\/ajtmh.17-0576.","journal-title":"Am J Trop Med Hyg"},{"key":"3918_CR129","unstructured":"Lee HC, Ko WC, Lee HL, Chen HY. Clinical manifestations and complications of rickettsiosis in southern Taiwan. J Formos Med Assoc. = Taiwan yi zhi. 2002; 101(6): 385\u201392."},{"key":"3918_CR130","doi-asserted-by":"publisher","first-page":"6613","DOI":"10.2147\/idr.S383917","volume":"15","author":"S Gao","year":"2022","unstructured":"Gao S, Li L, Zhou X, Dai X, Lu L, Chen Y, et al. Fatal Rickettsia Japonica infection complicating disseminated intravascular coagulation in Yichang. China Infect Drug Resist. 2022;15:6613\u201323. https:\/\/doi.org\/10.2147\/idr.S383917.","journal-title":"China Infect Drug Resist"},{"issue":"2","key":"3918_CR131","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.diagmicrobio.2010.08.022","volume":"69","author":"P Athanassopoulou","year":"2011","unstructured":"Athanassopoulou P, Liatsos G, Pirounaki M, Skounakis M, Moulakakis A. Disseminated intravascular coagulation as the laboratory hallmark of acute Q fever. Diagn Microbiol Infect Dis. 2011;69(2):210\u20132. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2010.08.022.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"3918_CR132","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2015-210808","author":"S Stevenson","year":"2015","unstructured":"Stevenson S, Gowardman J, Tozer S, Woods M. Life-threatening Q fever infection following exposure to kangaroos and wallabies. BMJ Case Rep. 2015. https:\/\/doi.org\/10.1136\/bcr-2015-210808.","journal-title":"BMJ Case Rep"},{"issue":"6","key":"3918_CR133","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jinf.2016.02.001","volume":"72","author":"DG Lalloo","year":"2016","unstructured":"Lalloo DG, Shingadia D, Bell DJ, Beeching NJ, Whitty CJM, Chiodini PL. UK malaria treatment guidelines 2016. J Infect. 2016;72(6):635\u201349. https:\/\/doi.org\/10.1016\/j.jinf.2016.02.001.","journal-title":"J Infect"},{"issue":"2","key":"3918_CR134","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1365-3156.2009.02434.x","volume":"15","author":"JF Wagenaar","year":"2010","unstructured":"Wagenaar JF, Goris MG, Partiningrum DL, Isbandrio B, Hartskeerl RA, Brandjes DP, et al. Coagulation disorders in patients with severe leptospirosis are associated with severe bleeding and mortality. Trop Med Int Health. 2010;15(2):152\u20139. https:\/\/doi.org\/10.1111\/j.1365-3156.2009.02434.x.","journal-title":"Trop Med Int Health"},{"issue":"8","key":"3918_CR135","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1099\/mic.0.000318","volume":"162","author":"LGV Fernandes","year":"2016","unstructured":"Fernandes LGV, Filho AFS, Souza GO, Vasconcellos SA, Romero EC, Nascimento A. Decrease in antithrombin III and prothrombin serum levels contribute to coagulation disorders during leptospirosis. Microbiology (Reading). 2016;162(8):1407\u201321. https:\/\/doi.org\/10.1099\/mic.0.000318.","journal-title":"Microbiology (Reading)"},{"key":"3918_CR136","doi-asserted-by":"publisher","unstructured":"Doi O, Takada Y, Yamauchi Y, Ogawa T. Systemic candidiasis with DIC and candida endophthalmitis in a postoperative neonate. Aust Paediatr J. 1989; 25(6): 372\u20135. https:\/\/doi.org\/10.1111\/j.1440-1754.1989.tb02362.x.","DOI":"10.1111\/j.1440-1754.1989.tb02362.x"},{"issue":"9","key":"3918_CR137","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.2169\/internalmedicine.9484-17","volume":"57","author":"Y Takayama","year":"2018","unstructured":"Takayama Y, Kubota T, Ogino Y, Ohnishi H, Togitani K, Yokoyama A. TAFRO syndrome with disseminated intravascular coagulation successfully treated with tocilizumab and recombinant thrombomodulin. Intern Med. 2018;57(9):1291\u20136. https:\/\/doi.org\/10.2169\/internalmedicine.9484-17.","journal-title":"Intern Med"},{"issue":"12","key":"3918_CR138","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.2169\/internalmedicine.42.1240","volume":"42","author":"T Tokashiki","year":"2003","unstructured":"Tokashiki T, Hashiguchi T, Arimura K, Eiraku N, Maruyama I, Osame M. Predictive value of serial platelet count and VEGF determination for the management of DIC in the Crow-Fukase (POEMS) syndrome. Inter Med. 2003;42(12):1240\u20133. https:\/\/doi.org\/10.2169\/internalmedicine.42.1240.","journal-title":"Inter Med"},{"issue":"2","key":"3918_CR139","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2131\/jts.31.157","volume":"31","author":"K Komori","year":"2006","unstructured":"Komori K, Konishi M, Maruta Y, Toriba M, Sakai A, Matsuda A, et al. Characterization of a novel metalloproteinase in Duvernoy\u2019s gland of Rhabdophis tigrinus tigrinus. J Toxicol Sci. 2006;31(2):157\u201368. https:\/\/doi.org\/10.2131\/jts.31.157.","journal-title":"J Toxicol Sci"},{"key":"3918_CR140","doi-asserted-by":"publisher","unstructured":"Komori Y, Hifumi T, Yamamoto A, Sakai A, Ato M, Sawabe K et al. Comparative Study of Biological Activities of Venom from Colubrid Snakes Rhabdophis tigrinus (Yamakagashi) and Rhabdophis lateralis. Toxins (Basel). 2017; 9(11). https:\/\/doi.org\/10.3390\/toxins9110373.","DOI":"10.3390\/toxins9110373"},{"issue":"7","key":"3918_CR141","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1080\/15563650.2018.1540045","volume":"57","author":"T Ichiki","year":"2019","unstructured":"Ichiki T, Kohda F, Hiramatsu T, Saiki R, Sakai A, Furue M. Early pathology in venom-induced consumption coagulopathy by Rhabdophis tigrinus (Yamakagashi snake) envenomation. Clin Toxicol (Philadelphia). 2019;57(7):668\u201371. https:\/\/doi.org\/10.1080\/15563650.2018.1540045.","journal-title":"Clin Toxicol (Philadelphia)"},{"issue":"1","key":"3918_CR142","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40560-014-0044-5","volume":"2","author":"T Hifumi","year":"2014","unstructured":"Hifumi T, Sakai A, Yamamoto A, Murakawa M, Ato M, Shibayama K, et al. Effect of antivenom therapy of Rhabdophis tigrinus (Yamakagashi snake) bites. J Intensive Care. 2014;2(1):44. https:\/\/doi.org\/10.1186\/s40560-014-0044-5.","journal-title":"J Intensive Care"},{"issue":"1","key":"3918_CR143","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40560-015-0081-8","volume":"3","author":"T Hifumi","year":"2015","unstructured":"Hifumi T, Sakai A, Kondo Y, Yamamoto A, Morine N, Ato M, et al. Venomous snake bites: clinical diagnosis and treatment. J Intensive Care. 2015;3(1):16. https:\/\/doi.org\/10.1186\/s40560-015-0081-8.","journal-title":"J Intensive Care"},{"issue":"1","key":"3918_CR144","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/2052-0492-2-19","volume":"2","author":"T Hifumi","year":"2014","unstructured":"Hifumi T, Sakai A, Yamamoto A, Murakawa M, Ato M, Shibayama K, et al. Clinical characteristics of yamakagashi (Rhabdophis tigrinus) bites: a national survey in Japan, 2000\u20132013. J Intensive Care. 2014;2(1):19. https:\/\/doi.org\/10.1186\/2052-0492-2-19.","journal-title":"J Intensive Care"},{"issue":"7","key":"3918_CR145","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1080\/15563650.2018.1540045","volume":"57","author":"T Ichiki","year":"2019","unstructured":"Ichiki T, Kohda F, Hiramatsu T, Saiki R, Sakai A, Furue M. Early pathology in venom-induced consumption coagulopathy by Rhabdophis tigrinus (Yamakagashi snake) envenomation. Clin Toxicol (Phila). 2019;57(7):668\u201371. https:\/\/doi.org\/10.1080\/15563650.2018.1540045.","journal-title":"Clin Toxicol (Phila)"},{"issue":"2","key":"3918_CR146","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/ams2.69","volume":"2","author":"T Hifumi","year":"2015","unstructured":"Hifumi T, Murakawa M, Sakai A, Ginnaga A, Yamamoto A, Ato M, et al. Potentially fatal coagulopathy secondary to yamakagashi (Rhabdophis tigrinus) bites that completely recovered with antivenom treatment. Acute Med Surg. 2015;2(2):123\u20136. https:\/\/doi.org\/10.1002\/ams2.69.","journal-title":"Acute Med Surg"},{"issue":"1","key":"3918_CR147","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1186\/s12893-021-01434-6","volume":"21","author":"J Wu","year":"2021","unstructured":"Wu J, Gong X, Hu Z, Sun Q. Acute liver failure caused by Amanita verna: a case series and review of the literature. BMC Surg. 2021;21(1):436. https:\/\/doi.org\/10.1186\/s12893-021-01434-6.","journal-title":"BMC Surg"},{"issue":"42","key":"3918_CR148","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3238\/arztebl.2020.0701","volume":"117","author":"R Wennig","year":"2020","unstructured":"Wennig R, Eyer F, Schaper A, Zilker T, Andresen-Streichert H. Mushroom poisoning. Dtsch Arztebl Int. 2020;117(42):701\u20138. https:\/\/doi.org\/10.3238\/arztebl.2020.0701.","journal-title":"Dtsch Arztebl Int"},{"issue":"2","key":"3918_CR149","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1177\/096032718800700218","volume":"7","author":"P Sanz","year":"1988","unstructured":"Sanz P, Reig R, Borr\u00e1s L, Mart\u00ednez J, M\u00e1\u00f1ez R, Corbella J. Disseminated intravascular coagulation and mesenteric venous thrombosis in fatal Amanita poisoning. Hum Toxicol. 1988;7(2):199\u2013201. https:\/\/doi.org\/10.1177\/096032718800700218.","journal-title":"Hum Toxicol"},{"issue":"3","key":"3918_CR150","first-page":"198","volume":"17","author":"D Soysal","year":"2006","unstructured":"Soysal D, Cevik C, Saklamaz A, Yetimalar Y, Unsal B. Coagulation disorders secondary to acute liver failure in Amanita phalloides poisoning: a case report. Turk J Gastroenterol. 2006;17(3):198\u2013202.","journal-title":"Turk J Gastroenterol"},{"issue":"3","key":"3918_CR151","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.wem.2021.02.009","volume":"32","author":"D Lai","year":"2021","unstructured":"Lai D, Tian Y, Zhang J, Weng CF. Hyperendogenous heparinization suggests a guideline for the management of massive wasp stings in two victims. Wilderness Environ Med. 2021;32(3):344\u201350. https:\/\/doi.org\/10.1016\/j.wem.2021.02.009.","journal-title":"Wilderness Environ Med"},{"issue":"3","key":"3918_CR152","first-page":"164","volume":"46","author":"JL Wang","year":"2005","unstructured":"Wang JL, Shen EY, Ho MY. Isolated prolongation of activated partial thromboplastin time following wasp sting. Acta Paediatr Taiwan. 2005;46(3):164\u20135.","journal-title":"Acta Paediatr Taiwan"},{"issue":"9","key":"3918_CR153","doi-asserted-by":"publisher","first-page":"629","DOI":"10.2217\/imt-2020-0018","volume":"12","author":"A Alberti","year":"2020","unstructured":"Alberti A, Mancin M, Cortinovis D, Bidoli P, Sala L. Disseminated intravascular coagulation in advanced lung adenocarcinoma during first-line pembrolizumab. Immunotherapy. 2020;12(9):629\u201333. https:\/\/doi.org\/10.2217\/imt-2020-0018.","journal-title":"Immunotherapy"},{"issue":"1","key":"3918_CR154","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s12185-020-02992-w","volume":"113","author":"T Ikezoe","year":"2021","unstructured":"Ikezoe T. Advances in the diagnosis and treatment of disseminated intravascular coagulation in haematological malignancies. Int J Hematol. 2021;113(1):34\u201344. https:\/\/doi.org\/10.1007\/s12185-020-02992-w.","journal-title":"Int J Hematol"}],"updated-by":[{"DOI":"10.1007\/s12185-025-03977-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000}}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-03918-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-025-03918-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-03918-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T10:48:38Z","timestamp":1745318918000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-025-03918-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":154,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["3918"],"URL":"https:\/\/doi.org\/10.1007\/s12185-025-03918-0","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12185-025-03977-3","asserted-by":"object"}]},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]},"assertion":[{"value":"3 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12185-025-03977-3","URL":"https:\/\/doi.org\/10.1007\/s12185-025-03977-3","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None of the authors have any potential conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}